iShares US Pharmaceuticals ETF
IHE
IHE
86 hedge funds and large institutions have $244M invested in iShares US Pharmaceuticals ETF in 2014 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 35 increasing their positions, 21 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
13% more funds holding
Funds holding: 76 → 86 (+10)
4.37% more ownership
Funds ownership: 106.95% → 111.31% (+4.4%)
Holders
86
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$6.43M | |
| 2 | +$5.61M | |
| 3 | +$4.23M | |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$3.64M |
| 5 |
CCMG
Clark Capital Management Group
Philadelphia,
Pennsylvania
|
+$2.73M |
Top Sellers
| 1 | -$2.74M | |
| 2 | -$1.99M | |
| 3 | -$1.71M | |
| 4 |
VKH
Virtu KCG Holdings
New York
|
-$1.49M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.24M |